FLECTOR Anti-Inflammatory Pain Relief Patch Available In US
Alpharma announced availability of FLECTOR Patch (diclofenac epolamine topical patch) 1.3%, the first and only anti-inflammatory pain relief patch in US. Available by prescription, the adhesive patch delivers medication directly to the site of pain, offering a safe and effective alternative to widely used nonsteroidal anti-inflammatory drugs (NSAIDs) that are taken orally. The targeted delivery of FLECTOR Patch through the skin results in minimal systemic absorption of diclofenac, one of the best selling and most widely used orally administered NSAIDs worldwide.
"The main drawback of commonly used oral anti-inflammatory medications is that many people cannot tolerate them," said Robert Sheu, M.D., Director of the Pain Division, Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York. "There are a lot of physicians and patients who would prefer a more targeted approach to treating pain at the site of an injury, and a topical patch accomplishes this while avoiding the stomach and digestive tract." Studies have shown that up to 50 percent of patients who suffer from pain have intolerance to traditional oral NSAIDs.
Acute pain is a common problem with one in four Americans suffering an episode of pain lasting longer than 24 hours. FLECTOR Patch is indicated for the topical treatment of acute pain due to minor strains, sprains and contusions.
In a national survey released today by the National Pain Foundation (NPF), supported by a grant from Alpharma Pharmaceuticals LLC, 93 percent of survey respondents expressed that people take too many pills, and 82 percent said they would be interested in a prescription pain relief patch that delivers medication directly to the point of pain. Further reinforcing the need for new pain relief therapies, the survey shows that only 22 percent of people were very satisfied with the current method they used to treat their pain.
About FLECTOR Patch